Skip to headlines

SCIENCE

Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy

ScienceDailyFriday, November 13, 2026 at 12:48 PM

RedScroll Brief

Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy
Image via ScienceDaily

A study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy, and similar drugs was not linked to increased pregnancy complications when used for weight loss, but was associated with a higher risk of premature birth when prescribed for diabetes.

RedScroll Signal

Impact
High
Category
Science
Market relevance
None
Why it matters
Scientific signal separates durable discovery from noise — and often foreshadows policy and product. A study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy, and similar drugs was not linked to increased pregnancy complications when used for weight loss, but was associated with a higher risk of premature birth when prescribed for diabetes.

Desk copy

RedScroll Briefing

Extractive editorial brief — not a reprint of the original

What happened

A study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy, and similar drugs was not linked to increased pregnancy complications when used for weight loss, but was associated with a higher risk of premature birth when prescribed for diabetes.

Why it matters

Scientific signal separates durable discovery from noise — and often foreshadows policy and product.

Background

ScienceDaily reported on this under science. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.

Timeline

  1. ScienceDaily published: Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy

  2. Story is in today’s RedScroll edition. Follow the original source for updates.

More on

Related stories

Source

ScienceDaily

Original reporting by ScienceDaily. RedScroll provides an extractive briefing only.